The Investing Iguana

The Investing Iguana

⚖️ Analyst Ratings Review

Maybank’s BUY Case for Addvalue Rests on a Viasat Deal. My Screen Runs on a Different Number Entirely.

Third-party validation from a US partner and a zero-dividend balance sheet are two different questions. Only one of them decides if this belongs anywhere near retirement money.

The Investing Iguana's avatar
The Investing Iguana
Sep 08, 2026
∙ Paid

Maybank’s BUY Case for Addvalue Rests on a Viasat Deal. My Screen Runs on a Different Number Entirely.

Third-party validation from a US partner and a zero-dividend balance sheet are two different questions. Only one of them decides if this belongs anywhere near retirement money.


Every BUY call needs a story its believers can repeat with confidence. Maybank’s story is Viasat, new orders, and a name most SGX portfolios have never had reason to check. The story is true. It isn’t the number that decides whether this belongs anywhere near CPF money.

I want to be upfront about something before the numbers: Addvalue’s actual FY2026 results are genuinely strong, revenue up 59.9 percent, net profit up 147.5 percent, and the balance sheet cleaner than it has been in years. None of that is in dispute. What is in dispute is whether “strong results plus a US partnership” answers the specific question a retirement portfolio needs answered, and that turns out to be a narrower question than the one Maybank’s report is answering.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.


  • The Analyst’s Case

  • THE LOAD-BEARING ASSUMPTION

  • The Window Is Already Open

  • Iggy’s Forensic Screen

  • Financial Health Checklist

  • Layer 1, Raw Fact

  • Layer 2, Historical Benchmark

  • Layer 3, Peer Context

  • Layer 4, Forward Scenario

  • Layer 5, Wallet Impact

  • The Dividend Trajectory

  • The Forensic Gap

  • 🟢 Iggy’s Insight

  • What To Watch Next

  • 🟢 Iggy’s Insight

  • Closing

  • Iggy’s Forensic Zone: Zone 5, Red Zone

  • Iggy’s Elite Read


The Analyst’s Case

Maybank Research reiterated a BUY on Addvalue Technologies (SGX: A31) on 4 September 2026, keeping its target price at S$0.34, built on 30 times FY27E price-to-sales.

The trigger is US$5.0 million in new orders: US$2.8 million for Inter-Satellite Data Relay System products, US$2.2 million for Advanced Digital Radio System products covering strategic design work and repeat supply of compact software-defined-radio modules to defence-technology customers. The company’s reported orderbook has grown to US$20.2 million.

The centrepiece is Viasat. Viasat will incorporate Addvalue’s IDRS terminals and services into its HaloNet portfolio for US government and government-supplier opportunities, with Addvalue positioned as the lead US-facing provider. Maybank reads this as third-party validation of Addvalue’s space communications capability, and a possible route to longer-duration, recurring orders from US space programmes, including potential exposure to organisations such as NASA. That prospective customer exposure is Maybank’s own reading, not a disclosed Addvalue contract, worth keeping separate from the confirmed order figures above.

The broader thesis frames Addvalue as a beneficiary of two high-growth themes, space communications and drone or anti-drone defence, with ADRS demand expected to strengthen in the second half of 2026 and potentially convert into larger multi-year contracts.

THE LOAD-BEARING ASSUMPTION: Maybank’s S$0.34 target depends on this orderbook converting into recurring, multi-year revenue at margins that justify a 30 times sales multiple, years before any of the Viasat-driven demand has actually been contracted, let alone delivered.

The Window Is Already Open

The Window Closes Fast. In this market, the difference between a “Sanctuary” and a “Yield Trap” is decided in a single trading session. By the time this analysis reaches you as a free subscriber, the entry window Iggy identified has already opened, and often closed.

Iggy’s Elite Investors don’t just get the report earlier. They get it when the numbers still matter, zero-day forensic breakdowns, the full “Red Zone” watchlist, and institutional-grade cheatsheets at the moment the setup is live, not after the market has already priced it in.

For S$12/month, less than two kopi and kaya toast sets at Raffles Place, you stop being the Exit Liquidity and start being the Analyst.

Join Team Iggy


Iggy’s Forensic Screen

Here’s where the analyst’s growth story meets a screen built for a different job entirely. My framework tests whether a stock can fund retirement income. Addvalue has never been asked that question by anyone, including itself.

Financial Health Checklist

Occupancy doesn’t appear on this table. That gate exists for REITs measuring how much of a building is earning rent. Addvalue manufactures satellite communication hardware, so the gate simply has nothing to measure here, not a waived test, an inapplicable one.

Layer 1, Raw Fact. At S$0.199 (4 September 2026, delayed quote, re-confirm against InvestingPro or Comet before this figure locks for publication), Addvalue trades at roughly 108 times trailing earnings against 3.68 billion shares outstanding, a market capitalisation north of S$700 million on FY2026 revenue of US$24.8 million. It pays no dividend and never has. Ordinary dividend yield: zero. Total dividend yield: zero. There is no basis to compute a trailing yield because no trailing distribution exists.

🔒 What’s Next

The balance sheet above clears every gate I run except one, and the one it fails isn’t a margin call, it’s a structural absence. The next section is where that distinction actually decides the verdict.

User's avatar

Continue reading this post for free, courtesy of The Investing Iguana.

Or purchase a paid subscription.
© 2026 Iggy the Investing Iguana · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture